Skip to main content
. 2024 Mar 12;115(5):1665–1679. doi: 10.1111/cas.16143

TABLE 2.

GEO cohorts in this study.

GEO datasets Samples PubMed identifier
GSE32225

149 Intrahepatic cholangiocarcinoma

6 Control

23295441
GSE67764 3 Hepatic carcinoma tissues 31385458
6 Control
GSE11819 4 Inflammatory hepatocellular adenomas 19020503
4 Control
GSE62029 7 Liver angioma 26459852
10 Control
GSE139602 5 Fibrosis (early chronic liver diseases) 35540106
8 Compensated cirrhosis
12 Decompensated cirrhosis
8 Acute‐on‐chronic liver failure
6 Control
GSE159676 12 Primary sclerosing cholangitis 35278227
7 Nonalcoholic steatohepatitis
8 Other liver diseases (i.e., primary biliary cholangitis, autoimmune hepatitis, alcoholic liver disease, and haemochromatosis)
5 Control